Key result
Pharmacist-led transitions of care linked to ~59% lower 30-day readmissions among multivisit patients.
Why the study?
Pharmacist-led transitions of care services decrease preventable hospital readmission, but assessment of TOC service implementation can inform translation to real-world settings.
Does a pharmacist-led transitions of care service reduce 30-day readmission rates in patients with multiple recent hospitalizations?
Observational (n=66)
No
Does a pharmacist-led transitions of care service reduce 30-day readmission rates in patients with multiple recent hospitalizations?
A pharmacist-led transitions of care service significantly reduced 30-day readmission rates in patients with multiple recent hospitalizations.
Should not yet change practice; supports randomized trials to confirm readmission reduction in multivisit patients.
Pharmacist-led transitions of care (TOC) services decrease preventable hospital readmission. TOC service implementation assessment can inform translation to real-world settings. The purpose of this study was to evaluate the implementation of a TOC service for patients with multiple admissions at a regional hospital using the RE-AIM framework. In this quasi-experimental, non-randomized study, individuals with ≥2 recent hospitalizations received pharmacist-led discharge medication reconciliation and counseling, management of drug-related problems, post-discharge telephonic visits, and social support. The reach, effectiveness, implementation, and maintenance RE-AIM dimensions were assessed using patient and service records. Outcomes included 30-day readmission rates for individuals completing ≥1 outpatient pharmacist visit (intervention) versus those unreachable in the outpatient setting (comparison), completed interventions, implementation features, and service adaptations. Chi-square and Fisher’s exact tests were used for comparison of categorical variables and the t-test was used for continuous variables. From February 2022 to August 2023, 72.7% of the 66 service participants participated in the intervention (reach). Additionally, 30-day readmission was 22.9% (intervention) versus 55.6% (comparison; p = 0.01). In total, 2279 interventions were documented (effectiveness). The service was adapted (implementation) and expanded to include additional populations (maintenance) to enhance sustainability. Based on RE-AIM evaluation, the pharmacist-led TOC intervention appears to be a sustainable solution for addressing readmission in multivisit patients.
No takes yet. Share an insight, caveat, or question.
Gamston et al. (2025) conducted an observational in Multivisit patients at high risk for readmission (n=66). Pharmacist-led transitions of care (TOC) service vs. Unreachable in the outpatient setting (comparison group) was evaluated on 30-day readmission rate (p=0.01). A pharmacist-led transitions of care service significantly reduced 30-day readmission rates to 22.9% compared to 55.6% in the comparison group (p=0.01) among multivisit patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: